Zeiher Bernhardt G — SEC Form 4 filings
SEC reporting owner CIK 1971421. 12 Form 4 filings on record with FilingPulse; latest filed 2026-06-12.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-03-15 to 2026-06-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 15,000 shares, $66,321 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 10.
- Largest priced transaction: purchase of 10,000 shares @ $3.70 ($37,005) in Amylyx Pharmaceuticals, Inc., filed 2025-03-24.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Amylyx Pharmaceuticals, Inc. (AMLX) | Director | 5 | 1 leg · 10,000 sh · $37,005 | — | 4 |
| Entrada Therapeutics, Inc. (TRDA) | Director | 4 | 1 leg · 5,000 sh · $29,316 | — | 3 |
| ABEONA THERAPEUTICS INC. (ABEO) | Director | 3 | — | — | 3 |
Form 4 filings — Zeiher Bernhardt G
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-12 | 4 | Entrada Therapeutics, Inc. (TRDA) | Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Grant/award (A): 24,372 (derivative) @ $0 | EDGAR |
| 2026-05-21 | 4 | Entrada Therapeutics, Inc. (TRDA) | Purchase (P): 5,000 @ $5.86 | EDGAR |
| 2026-01-27 | 4 | ABEONA THERAPEUTICS INC. (ABEO) | Grant/award (A): 37,313 @ $0 | EDGAR |
| 2025-06-12 | 4 | Entrada Therapeutics, Inc. (TRDA) | Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2025-03-24 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Purchase (P): 10,000 @ $3.70 | EDGAR |
| 2025-02-03 | 4 | ABEONA THERAPEUTICS INC. (ABEO) | Grant/award (A): 36,101 @ $0 | EDGAR |
| 2024-08-14 | 4 | ABEONA THERAPEUTICS INC. (ABEO) | Grant/award (A): 11,044 @ $0 | EDGAR |
| 2024-06-14 | 4 | Entrada Therapeutics, Inc. (TRDA) | Grant/award (A): 16,000 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Grant/award (A): 5,753 (derivative) @ $0 | EDGAR |
| 2024-03-15 | 4 | Amylyx Pharmaceuticals, Inc. (AMLX) | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1971421 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →